Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06081140 · ClinicalTrials.gov registry record · NA

Tolerance and Palatability of 10-day Supplementation With Hemp Oil, Calamari Oil, and Broccoli Extract in Healthy Adults

A NA study, sponsored by Standard Process.

Completed
Registry status
NA
Development phase
14
Enrollment target

NCT06081140 is a NA study that has completed, run by Standard Process. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06081140, a NA study, has completed, sponsored by Standard Process.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

Tolerance and palatability of short-term supplementation with a whole-food dietary formulation based on hemp oil, calamari oil, and broccoli was evaluated in healthy adults. This was a 10-day open-label, prospective, controlled trial (n=14) in which participants acted as their own controls to receive daily intervention standardized to contain 15 mg phytocannabinoids, 230 mg omega-3 fatty acids, and 5 mg glucoraphanin. The primary objective was to evaluate gastrointestinal tolerability and acceptability. The study demonstrated that daily ingestion of the investigational product was well tolerated with no or minor adverse events, and a good palatability. The secondary objectives were to access parameters of blood biochemistry, liver enzymes, biomarkers of immune and oxi-dative health, as well as phytocannabinoid profiles in urine.

Interventions

  • DIETARY_SUPPLEMENT Standard Process Hemp Oil Complex

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2019-04-26
Est. Completion 2019-05-26
Phase NA

Sponsor

Standard Process

8 total trials

What the Registry Record Tells You About NCT06081140

The ClinicalTrials.gov registry entry for NCT06081140 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Standard Process, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Standard Process Hemp Oil Complex is the first listed.

NCT06081140 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06081140 about?

NCT06081140 is a clinical study titled "Tolerance and Palatability of 10-day Supplementation With Hemp Oil, Calamari Oil, and Broccoli Extract in Healthy Adults". Tolerance and palatability of short-term supplementation with a whole-food dietary formulation based on hemp oil, calamari oil, and broccoli was evaluated in healthy adults. This was a 10-day open-label, prospective, controlled trial (n=14) in which participants acted as their own controls to receiv...

What is the current status of trial NCT06081140?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2019-04-26. Estimated completion is 2019-05-26.

What interventions are being tested in trial NCT06081140?

The interventions under investigation include: Standard Process Hemp Oil Complex (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06081140?

This trial is sponsored by Standard Process, which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.